These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [The regulation of anoikis in tumor invasion and metastasis]. Su H; Si XY; Tang WR; Luo Y Yi Chuan; 2013 Jan; 35(1):10-6. PubMed ID: 23357260 [TBL] [Abstract][Full Text] [Related]
46. Extracellular matrix regulation of metabolism and implications for tumorigenesis. Grassian AR; Coloff JL; Brugge JS Cold Spring Harb Symp Quant Biol; 2011; 76():313-24. PubMed ID: 22105806 [TBL] [Abstract][Full Text] [Related]
47. A novel anti-cancer agent, FPDHP, induces anoikis in various human cancer cells through activation of calpain, and downregulation of anoikis-related molecules. Kim SG; Yooun JH; Kim DE; Lee ES; Kwon TK; Kim S; Park JW J Cell Biochem; 2018 Jul; 119(7):5620-5631. PubMed ID: 29388704 [TBL] [Abstract][Full Text] [Related]
48. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Khan SU; Fatima K; Malik F Clin Exp Metastasis; 2022 Oct; 39(5):715-726. PubMed ID: 35829806 [TBL] [Abstract][Full Text] [Related]
49. Understanding and targeting anoikis in metastasis for cancer therapies. Sattari Fard F; Jalilzadeh N; Mehdizadeh A; Sajjadian F; Velaei K Cell Biol Int; 2023 Apr; 47(4):683-698. PubMed ID: 36453448 [TBL] [Abstract][Full Text] [Related]
50. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Buchheit CL; Weigel KJ; Schafer ZT Nat Rev Cancer; 2014 Sep; 14(9):632-41. PubMed ID: 25098270 [TBL] [Abstract][Full Text] [Related]
52. Assessment of resistance to anoikis in ovarian cancer. He X; Chien J; Shridhar V Methods Mol Biol; 2013; 1049():347-54. PubMed ID: 23913229 [TBL] [Abstract][Full Text] [Related]
53. Bit1 in anoikis resistance and tumor metastasis. Jenning S; Pham T; Ireland SK; Ruoslahti E; Biliran H Cancer Lett; 2013 Jun; 333(2):147-51. PubMed ID: 23376255 [TBL] [Abstract][Full Text] [Related]
54. Metabolism during ECM Detachment: Achilles Heel of Cancer Cells? Mason JA; Hagel KR; Hawk MA; Schafer ZT Trends Cancer; 2017 Jul; 3(7):475-481. PubMed ID: 28718402 [TBL] [Abstract][Full Text] [Related]
55. Anchorage Dependence and Cancer Metastasis. Lee DK; Oh J; Park HW; Gee HY J Korean Med Sci; 2024 May; 39(19):e156. PubMed ID: 38769921 [TBL] [Abstract][Full Text] [Related]
56. Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment. Dai Y; Zhang X; Ou Y; Zou L; Zhang D; Yang Q; Qin Y; Du X; Li W; Yuan Z; Xiao Z; Wen Q Cell Commun Signal; 2023 Aug; 21(1):190. PubMed ID: 37537585 [TBL] [Abstract][Full Text] [Related]
57. Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming. Adeshakin FO; Adeshakin AO; Afolabi LO; Yan D; Zhang G; Wan X Front Oncol; 2021; 11():626577. PubMed ID: 33854965 [TBL] [Abstract][Full Text] [Related]
58. The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment. Gulia S; Chandra P; Das A Cell Biochem Biophys; 2023 Dec; 81(4):621-658. PubMed ID: 37787970 [TBL] [Abstract][Full Text] [Related]
59. Integration of autophagy and anoikis resistance in solid tumors. Yang J; Zheng Z; Yan X; Li X; Liu Z; Ma Z Anat Rec (Hoboken); 2013 Oct; 296(10):1501-8. PubMed ID: 23963853 [TBL] [Abstract][Full Text] [Related]
60. Targeting anoikis resistance as a strategy for cancer therapy. Wang Y; Cheng S; Fleishman JS; Chen J; Tang H; Chen ZS; Chen W; Ding M Drug Resist Updat; 2024 Jul; 75():101099. PubMed ID: 38850692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]